Martin-Perez, E. http://orcid.org/0000-0002-4933-738X
Domínguez-Muñoz, J. E.
Botella-Romero, F.
Cerezo, L.
Matute Teresa, F.
Serrano, T.
Vera, R.
Funding for this research was provided by:
Spanish Society of Medical Oncology
Spanish Association of Surgeons
Spanish Society of Radiation Oncology
Spanish Society of Endocrinology and Nutrition
Spanish Society of Digestive Pathology
Spanish Society of Medical Radiology
Spanish Society of Pathology
Article History
Received: 5 December 2019
Accepted: 1 April 2020
First Online: 21 April 2020
Compliance with ethical standards
:
: E. Martin-Perez has received speaker honorarium from Ipsen, Novartis, Baxter and Pfizer, outside the submitted work. J.E. Domínguez has received speaker honorarium from Mylan and Abbott Laboratories, and advisory honorarium from Mylan. F. Botella-Romero declares no conflict of interest in relation with this manuscript. L. Cerezo. declares no conflict of interest in relation with this manuscript. F. Matute declares no conflict of interest in relation with this manuscript. T. Serrano declares no conflict of interest in relation with this manuscript. R. Vera has received consultant fees from Roche, Amgen, Merck Sharp & Dohme, Sanofi & Bristol Myer Squibb also has received advisory honorarium from Roche, Amgen, Merck Sharp & Dohme, Sanofi.
: The manuscript does not contain any studies with human participants or animals performed by any of the authors.
: Informed Consent/ethical approval is not required for this type of project.